185 related articles for article (PubMed ID: 20189618)
1. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.
Raslan HM; Elhosary Y; Ezzat WM; Rasheed EA; Rasheed MA
Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):429-32. PubMed ID: 20189618
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.
Gallego-Rojo FJ; Gonzalez-Calvin JL; Muñoz-Torres M; Mundi JL; Fernandez-Perez R; Rodrigo-Moreno D
Hepatology; 1998 Sep; 28(3):695-9. PubMed ID: 9731561
[TBL] [Abstract][Full Text] [Related]
3. Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.
Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):38-43. PubMed ID: 14758570
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
[TBL] [Abstract][Full Text] [Related]
5. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women.
Karasik D; Rosen CJ; Hannan MT; Broe KE; Dawson-Hughes B; Gagnon DR; Wilson PW; Visser M; Langlois JA; Mohan S; Kiel DP
Calcif Tissue Int; 2002 Oct; 71(4):323-8. PubMed ID: 12202958
[TBL] [Abstract][Full Text] [Related]
7. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
[TBL] [Abstract][Full Text] [Related]
8. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
[TBL] [Abstract][Full Text] [Related]
9. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
10. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
11. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
[TBL] [Abstract][Full Text] [Related]
12. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I and mineral metabolism markers in children with idiopathic decrease in bone mass.
Rusińska A; Chlebna-Sokół D
Clin Chim Acta; 2006 Apr; 366(1-2):257-63. PubMed ID: 16330010
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
Chlebna-Sokol D; Rusinska A
Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
[TBL] [Abstract][Full Text] [Related]
16. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.
Toussirot E; Nguyen NU; Dumoulin G; Aubin F; Cédoz JP; Wendling D
Rheumatology (Oxford); 2005 Jan; 44(1):120-5. PubMed ID: 15466894
[TBL] [Abstract][Full Text] [Related]
17. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
Wang H; Wan YX; Zhang QK
Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678
[TBL] [Abstract][Full Text] [Related]
18. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats.
Novosyadlyy R; Dargel R; Scharf JG
Growth Horm IGF Res; 2005 Oct; 15(5):313-23. PubMed ID: 16098781
[TBL] [Abstract][Full Text] [Related]
19. Bone metabolism and mineral density in patients with beta-thalassemia major.
Dundar U; Kupesiz A; Ozdem S; Gilgil E; Tuncer T; Yesilipek A; Gultekin M
Saudi Med J; 2007 Sep; 28(9):1425-9. PubMed ID: 17768474
[TBL] [Abstract][Full Text] [Related]
20. [Decreased bone mineral density and gene polymorphism in primary biliary cirrhosis].
Lakatos PL; Bajnok E; Tornai I; Folhoffer A; Horváth A; Lakatos P; Szalay F
Orv Hetil; 2004 Feb; 145(7):331-6. PubMed ID: 15049048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
